It contains the same active ingredient as Ozempic and Wegovy semaglutide and studies show it is about as effective as the injections when it comes to weight loss
Visible skin improvements, including brighter tone and reduced pigmentation, typically appear after 4 to 8 weeks of consistent use
Seino et al., 2018
Gut microbiome composition represents another potentially important variable, though its specific role in allulose metabolism requires further investigation
Krekels EH, van Ham S, Allegaert K, de Hoon J, Tibboel D, Danhof M, et al
In a clinical trial comparing Zepbound (tirzepatide) with Wegovy (semaglutide), people taking Zepbound achieved an average weight loss of 20.2% of their starting weight compared to 13.7% for those taking Wegovy